Evolving therapeutic goals in Crohn's disease management

被引：12
|
作者：
Chateau, Thomas [1 ,2 ,3 ]
Peyrin-Biroulet, Laurent [2 ,3 ]
机构：
[1] Univ Grenoble Alpes, Univ Hosp Grenoble, Dept Hepatogastroenterol, Grenoble, France
[2] Univ Lorraine, Dept Gastroenterol, Univ Hosp Nancy, Vandoeuvre Les Nancy, France
[3] Univ Lorraine, Inserm NGERE, Univ Hosp Nancy, Vandoeuvre Les Nancy, France
来源：
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL | 2020年 / 8卷 / 02期
关键词：
Tight control; Crohn's disease; treat-to-target; INFLAMMATORY-BOWEL-DISEASE; C-REACTIVE PROTEIN; FECAL CALPROTECTIN; ENDOSCOPIC ACTIVITY; CLINICAL RELAPSE; DEEP REMISSION; ACTIVITY INDEX; INFLIXIMAB; AZATHIOPRINE; MULTICENTER;
D O I：
10.1177/2050640619887316
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The main objectives in Crohn's disease are to avoid disease complications and preserve the patient's quality of life. Early disease control and close monitoring with specific targets to reach might be the only way to change the disease course. In two decades, we have moved from clinical response to full remission (clinical and endoscopic remission) requiring a tight monitoring of both symptoms and objective signs of inflammation. This review summarizes the concepts of tight control and treat-to-target and their potential for disease modification.
引用
收藏
页码：133 / 139
页数：7
相关论文
共 50 条
  • [21] Management of Crohn's disease
    Kammermeier, Jochen
    Morris, Mary-Anne
    Garrick, Vikki
    Furman, Mark
    Rodrigues, Astor
    Russell, Richard K.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (05) : 475 - 480
  • [22] Management of Crohn's disease
    Lamb, C. A.
    Speight, R. A.
    Needham, S.
    Graham, J. Y.
    Mansfield, J. C.
    GUT, 2010, 59 (03) : 340 - 340
  • [23] Evolving medical therapies for Crohn's disease.
    Mahadevan U.
    Sandborn W.J.
    Current Gastroenterology Reports, 2001, 3 (6) : 471 - 476
  • [24] EVOLVING PULMONARY SYMPTOMS IN A PATIENT WITH CROHN'S DISEASE
    Chan, Kathy L.
    Zafar, Bilal
    Bashour, Sami
    Grosu, Horiana B.
    Bashoura, Lara
    Faiz, Saadia A.
    CHEST, 2023, 164 (04) : 5510A - 5511A
  • [25] Intra-abdominal abscesses in Crohn's disease: diagnosis and therapeutic management
    Bedioui, H.
    Baraket, O.
    Daghfous, A.
    Chaker, Y.
    Ayadi, S.
    Makni, A.
    Rebai, W.
    Chebbi, F.
    Ksontini, R.
    Jouini, M.
    Kacem, M.
    Ben Safta, Z.
    JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE, 2012, 6 (02): : 96 - 102
  • [26] New therapeutic approaches to Crohn's disease
    Cézard, JP
    Hugot, JP
    ARCHIVES DE PEDIATRIE, 2001, 8 : 406S - 408S
  • [27] Subgroups of Crohn's disease - are there therapeutic differences?
    Gasche, C.
    INTESTINAL DISORDERS, 2009, 164 : 77 - 85
  • [28] Expanding therapeutic options in Crohn's disease
    Chapman, Thomas P.
    Satsangi, Jack
    LANCET, 2024, 404 (10470): : 2396 - 2398
  • [29] Therapeutic drug monitoring in Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (03): : 150 - 150
  • [30] Understanding Therapeutic Concepts in Crohn's Disease
    Monif, Gilles R. G.
    CLINICAL MEDICINE INSIGHTS-GASTROENTEROLOGY, 2018, 11
12345